Electrophysiologic endpoint measures in a multicenter ALS drug trial

Journal of the Neurological Sciences

Volumn 184, Issue 1, 2001, Pages 51-55

  Bromberg, M B ^a   Fries, T J ^b   Forshew, D A ^a   Tandan, R ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

Amyotrophic lateral sclerosis (ALS); Drug efficacy trials; Electrophysiology; EMG; Endpoint measures

Indexed keywords

BRANCHED CHAIN AMINO ACID; ISOLEUCINE; LEUCINE; PLACEBO; PYRIDOXAL 5 PHOSPHATE; THREONINE; VALINE;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; MOTONEURON; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REINNERVATION;

AMINO ACIDS, BRANCHED-CHAIN; AMYOTROPHIC LATERAL SCLEROSIS; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; ELECTROPHYSIOLOGY; ENDPOINT DETERMINATION; HUMANS; MOTOR NEURONS; REPRODUCIBILITY OF RESULTS;

EID: 0035864902     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(00)00489-5     Document Type: Article

References (30)

1. Motor neuron disease
2. Electrodiagnostic studies in clinical trials for motor neuron disease
3. Group TARS. A controlled trial of riluzole in amyotrophic lateral sclerosis
4. Group ALSRS. Dose-ranging study of riluzole in amyotrophic lateral sclerosis
5. A controlled trial of amino acid therapy in amyotrophic lateral sclerosis: I: Clinical, functional, and maximum isometric torque data
6. El escorial world federation of neurology criteria for the diagnosis of amyotrophic lateral sclerosis
7. Methods for estimating numbers of motor units in biceps-brachialis muscles and losses of motor units with aging
8. Macro EMG, a new recording technique
9. Motor unit fibre density in the extensor digitorum communis muscle
10. Motor unit number estimation, isometric strength, and electromyographic measures in amyotrophic lateral sclerosis
11. Motor unit estimation: Reproducibility of the spike-triggered averaging technique in normal and ALS subjects
12. The natural history of amyotrophic lateral sclerosis and the use of natural history controls in therapeutic trials
13. Functional compensation in partially denervated muscles
14. End point measurements in clinical trials in amyotrophic lateral sclerosis
15. Use of composite scores (megascores) to measure deficit in amyotrophic lateral sclerosis
16. The amyotrophic lateral sclerosis functional rating scale
17. The administration of guanidine in amyotrophic lateral sclerosis
18. A rating scale for amyotrophic lateral sclerosis: Description and preliminary experience
19. A review of techniques employed to estimate the number of motor units in a muscle
20. Invited review: Motor unit estimation: Methods, results, and present status
21. Quantitative motor assessment in amyotrophic lateral sclerosis
22. Sources of error in the spike-triggered averaging method of motor unit number estimation (mune)
23. The influence of active electrode placement on CMAP amplitude
24. Influence of recording site on CMAP amplitude and on its variation over a length of nerve
25. CMAP amplitude cartography of muscles innervated by the median, ulnar, peroneal, and tibial nerves
26. Airlie house guidelines. therapeutic trials in amyotrophic lateral sclerosis
27. Longitudinal electrodiagnostic studies in amyotrophic lateral sclerosis patients treated with recombinant human ciliary neurotrophic factor
28. A longitudinal study comparing thenar motor unit number estimates to other quantitative tests in patients with amyotrophic lateral sclerosis
29. Longitudinal study of fiber density and motor unit number estimate in patients with amyotrophic lateral sclerosis
30. Electrophysiological studies of reinnervation in als